Next Article in Journal / Special Issue
Shaping the Innate Immune Response by Dietary Glucans: Any Role in the Control of Cancer?
Previous Article in Journal
The Regulation of the Metastatic Cascade by Physical Activity: A Narrative Review
Previous Article in Special Issue
Targeted Nano-Drug Delivery of Colchicine against Colon Cancer Cells by Means of Mesoporous Silica Nanoparticles
 
 
Review
Peer-Review Record

Targeting Glucose Transporters for Breast Cancer Therapy: The Effect of Natural and Synthetic Compounds

Cancers 2020, 12(1), 154; https://doi.org/10.3390/cancers12010154
by Ana M. Barbosa 1 and Fátima Martel 2,3,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Cancers 2020, 12(1), 154; https://doi.org/10.3390/cancers12010154
Submission received: 6 December 2019 / Revised: 6 January 2020 / Accepted: 7 January 2020 / Published: 8 January 2020
(This article belongs to the Special Issue Role of Natural Bioactive Compounds in the Rise and Fall of Cancers)

Round 1

Reviewer 1 Report

In this review, the Authors aimed to discuss the natural and synthetic compounds that interfere with the uptake of glucose by breast cancer cells, thus may act as anticancer agents due to the ability to inhibit tumor progression.

The topic is interesting and the information timely. As stated by the Authors GLUT expression correlates with a high malignant potential, invasiveness and consequently a poor prognosis. Therefore, it could be interesting if the Authors would provide mechanistic data regarding the regulation of GLUT genes in breast malignancies.

Author Response

Thank you very much for the helpful comments. Shown next, we changed the manuscript according to your criticisms, and we think it has improved.

 

Reviewer 1

 

It could be interesting if the Authors would provide mechanistic data regarding the regulation of GLUT genes in breast malignancies.

 

In agreement with your proposal, this information was added (lines 102-111). The text concerning GLUT1 upregulation in cancer was also slightly changed, for a better coherence (lines 87-101).

Reviewer 2 Report

This manuscript is a review of what is known regarding glucose transport in response to breast cancer therapy. The authors discuss the general phenomenon of increased glucose transport in cancer and the rationale behind these transporters being therapeutic targets. The bulk of the review focuses on drugs that directly target glucose transport, either synthetic exogenous compounds, natural exogenous compounds, and natural endogenous effectors of glucose transport. The last section focuses on the effect of targeting cancer cells by targeting glucose transporters. The following comments are intended to improve the manuscript:

Comments:

There are several sections of the manuscript where there are very short paragraphs (≤3 sentences) but the adjacent paragraphs are part of the same point the authors are trying to make. It may be easier for readers if the manuscript was edited and some of these paragraphs joined together. The tables includes are helpful in their level of detail but are very cumbersome to consume. Perhaps some thought should be given to restructuring them to make it easier to take in. While the current version of the review is substantial in length, something helpful to add may be a better description in the introduction of how glucose transporters function normally.

Author Response

Thank you very much for the helpful comments. Shown next, we changed the manuscript according to your criticisms, and we think it has improved.

 

Reviewer 2

 

There are several sections of the manuscript where there are very short paragraphs (≤3 sentences) but the adjacent paragraphs are part of the same point the authors are trying to make. It may be easier for readers if the manuscript was edited and some of these paragraphs joined together.

 

In agreement with this criticism, various paragraphs were joined together, throughout the manuscript.

 

The tables includes are helpful in their level of detail but are very cumbersome to consume. Perhaps some thought should be given to restructuring them to make it easier to take in.

 

Following your comment, we made some changes in the tables that we think make them easier to read.

 

While the current version of the review is substantial in length, something helpful to add may be a better description in the introduction of how glucose transporters function normally.

In agreement with your criticism, this information was added (lines 69-74 and 79-83).

 

 

Back to TopTop